Faraday Pharmaceuticals

1616 Eastlake Ave E Ste 560
Seattle, WA 98102

Faraday Pharmaceuticals, based in Seattle, WA, is a pioneering biotech company focused on developing innovative solutions for cardiovascular health. Their lead program, FDY-5301, targets ischemia-reperfusion injury to reduce cardiac damage and heart failure in patients who have experienced myocardial infarctions.

Founded by Dr. Mark Roth of the Fred Hutchinson Cancer Center, Faraday Pharmaceuticals is dedicated to investigating sodium iodide as a novel approach to addressing ischemia-reperfusion injury. Their Phase 3 clinical trial, Iocyte AMI-3, aims to evaluate the potential of FDY-5301 in reducing heart failure and cardiovascular death among patients with anterior ST-elevation myocardial infarction.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesWashingtonSeattleFaraday Pharmaceuticals

Partial Data by Foursquare.